RXO (NYSE:RXO – Get Free Report) had its price objective boosted by equities researchers at Stifel Nicolaus from $26.00 to $27.00 in a report issued on Thursday,Benzinga reports. The firm presently has a “hold” rating on the stock. Stifel Nicolaus’ price target points to a potential upside of 4.15% from the stock’s previous close.
A number of other equities research analysts have also weighed in on RXO. Jefferies Financial Group decreased their target price on RXO from $33.00 to $30.00 and set a “buy” rating for the company in a research report on Friday, January 10th. The Goldman Sachs Group reaffirmed a “neutral” rating and issued a $29.00 price objective on shares of RXO in a research note on Monday, November 18th. Susquehanna cut their target price on shares of RXO from $16.00 to $12.00 and set a “negative” rating on the stock in a research report on Tuesday, November 12th. Barclays lowered their price target on shares of RXO from $32.00 to $30.00 and set an “overweight” rating for the company in a research report on Friday, January 17th. Finally, Benchmark reissued a “hold” rating on shares of RXO in a report on Wednesday, January 15th. Two investment analysts have rated the stock with a sell rating, eleven have given a hold rating and three have issued a buy rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average price target of $26.79.
RXO Stock Performance
RXO (NYSE:RXO – Get Free Report) last issued its quarterly earnings data on Thursday, November 7th. The company reported $0.05 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.04 by $0.01. RXO had a positive return on equity of 1.64% and a negative net margin of 6.81%. The business had revenue of $1.04 billion for the quarter, compared to the consensus estimate of $956.19 million. During the same period in the prior year, the business posted $0.05 earnings per share. The company’s quarterly revenue was up 6.6% compared to the same quarter last year. On average, research analysts predict that RXO will post 0.12 EPS for the current fiscal year.
Institutional Inflows and Outflows
Hedge funds have recently bought and sold shares of the business. FMR LLC grew its holdings in RXO by 439.5% during the 3rd quarter. FMR LLC now owns 47,837 shares of the company’s stock worth $1,339,000 after acquiring an additional 38,970 shares in the last quarter. Harbor Capital Advisors Inc. bought a new position in shares of RXO during the fourth quarter worth about $2,004,000. JPMorgan Chase & Co. grew its stake in RXO by 71.8% in the third quarter. JPMorgan Chase & Co. now owns 272,062 shares of the company’s stock worth $7,618,000 after purchasing an additional 113,685 shares in the last quarter. Citigroup Inc. raised its stake in RXO by 132.4% during the third quarter. Citigroup Inc. now owns 196,748 shares of the company’s stock valued at $5,509,000 after buying an additional 112,073 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. lifted its holdings in RXO by 7.1% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 2,068,380 shares of the company’s stock worth $57,915,000 after buying an additional 136,886 shares during the last quarter. Hedge funds and other institutional investors own 92.73% of the company’s stock.
About RXO
RXO, Inc provides full truckload freight transportation brokering services. It also offers brokered services for managed transportation, last mile, and freight forwarding. The company was incorporated in 2022 and is based in Charlotte, North Carolina.
See Also
- Five stocks we like better than RXO
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- Why Energy Transfer Stock Could Soar to New Highs in 2025
- What is a Low P/E Ratio and What Does it Tell Investors?
- 3 Buy-and-Hold Stocks for Long-Term Growth
- How to Use the MarketBeat Dividend Calculator
- Despite Short-Term Risks Freeport McMoran Worth a Look
Receive News & Ratings for RXO Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RXO and related companies with MarketBeat.com's FREE daily email newsletter.